Form 13-F position report

XTANT MED HLDGS INC

Reported by MORGAN STANLEY

BONE CUSIP 98420P308 Manager CIK 0000895421

Reported 1,125 shares, unchanged from the prior quarter.

Reported value -15.8%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value < 0.01% This manager · Q3 2026
Shares 1,125 Quarter-end amount reported
Reported value $399 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0
2022-03-31 0
2022-06-30 0
2022-09-30 0
2022-12-31 205
2023-03-31 198
2023-06-30 289
2023-09-30 32
2023-12-31 0
2024-03-31 1492
2024-06-30 0
2025-12-31 882
2026-03-31 628
2026-06-30 474
2026-09-30 399

Quarterly position history

How this manager's reported quarter-end position changed over time.

15 quarters
Quarterly reported position history for XTANT MED HLDGS INC held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 1,125 0 (0.0%) < 0.01% $399 2026-11-13
Q2 2026 Unchanged 1,125 0 (0.0%) < 0.01% $474 2026-08-13
Q1 2026 Unchanged 1,125 0 (0.0%) < 0.01% $628 2026-05-15
Q4 2025 New 1,125 +1,125 (0.0%) < 0.01% $882 2026-02-13
Q2 2024 Reduced 0 -1,275 (-100.0%) 0 $0 2024-08-14
Q1 2024 New 1,275 +1,275 (0.0%) < 0.01% $1,492 2024-05-15
Q4 2023 Reduced 0 -29 (-100.0%) 0 $0 2024-02-13
Q3 2023 Reduced 29 -282 (-90.7%) < 0.01% $32 2023-11-15
Q2 2023 Unchanged 311 0 (0.0%) < 0.01% $289 2023-08-14
Q1 2023 Unchanged 311 0 (0.0%) < 0.01% $198 2023-05-15
Q4 2022 Added 311 +281 (936.7%) < 0.01% $205 2023-02-14
Q3 2022 Added 30 +1 (3.4%) 0 $0 2022-11-14
Q2 2022 Reduced 29 -9 (-23.7%) 0 $0 2022-08-15
Q1 2022 Added 38 +8 (26.7%) 0 $0 2022-05-13
Q4 2021 Added 30 +1 (3.4%) 0 $0 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

39 managers reported XTANT MED HLDGS INC for Q3 2026.

Managers reporting XTANT MED HLDGS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Nantahala Capital Management LLC Unchanged 68,394,000 0 0.77% $24,286,710 13 qtrs
AWM Investment Company Inc Added 6,164,288 +187,378 0.21% $2,188,939 6 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Unchanged 2,014,603 0 < 0.01% $715,184 3 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 517,133 0 < 0.01% $183,685 23 qtrs
Crescent Grove Advisors LLC Unchanged 412,024 0 0.01% $146,310 20 qtrs
NANO CAP NEW MILLENNIUM GROWTH FUND L P Reduced 350,000 -50,000 0.09% $124,285 4 qtrs
VANGUARD FIDUCIARY TRUST CO Unchanged 257,988 0 < 0.01% $91,586 3 qtrs
HRT FINANCIAL LP Added 187,625 +168,028 < 0.01% $66,000 2 qtrs
WIREGRASS INVESTMENT MANAGEMENT LLC Unchanged 150,000 0 0.04% $53,265 4 qtrs
JANE STREET GROUP LLC New 136,966 +136,966 < 0.01% $48,637 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
0
Shared
0
None
1,125

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.